Association of circulating blood HMGB1 levels with ischemic stroke: a systematic review and meta-analysis

Postischemic Inflammation in Acute Stroke

(2017) Simone Vidale et al.   Journal of Clinical Neurology

Elevated Serum High-Mobility Group Box-1 Protein Level Is Associated with Poor Functional Outcome in Ischemic Stroke

(2017) Toshiyuki Tsukagawa et al.   Journal of Stroke & Cerebrovascular Diseases

Elevated Serum High-Mobility Group Box-1 Protein Level Is Associated with Poor Functional Outcome in Ischemic Stroke

(2017) Toshiyuki Tsukagawa et al.   Journal of Stroke & Cerebrovascular Diseases

HMGB1 as a Key Mediator of Immune Mechanisms in Ischemic Stroke

(2016) Vikramjeet Singh et al.   ANTIOXIDANTS & REDOX SIGNALING

Executive Summary: Heart Disease and Stroke Statistics—2016 Update

(2016) Dariush Mozaffarian et al.   CIRCULATION

Inflammation after Ischemic Stroke: The Role of Leukocytes and Glial Cells

(2016) Jong Youl Kim et al.   Experimental Neurobiology

DAMP Signaling is a Key Pathway Inducing Immune Modulation after Brain Injury

(2015) A. Liesz et al.   JOURNAL OF NEUROSCIENCE

Peripheral Frequency of CD4+ CD28− Cells in Acute Ischemic Stroke

(2015) Antonino Tuttolomondo et al.   MEDICINE

Correlation between MMP-9 and extracellular cytokine HMGB1 in prediction of human ischemic stroke outcome

(2014) Nelly Sapojnikova et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Molecular dialogs between the ischemic brain and the peripheral immune system: Dualistic roles in injury and repair

(2014) Chengrui An et al.   PROGRESS IN NEUROBIOLOGY

HMGB1 in vascular diseases: Its role in vascular inflammation and atherosclerosis

(2012) A.W.S. de Souza et al.   AUTOIMMUNITY REVIEWS

Effects of ACE-Inhibitors and Angiotensin Receptor Blockers on Inflammation

(2012) D. Di Raimondo et al.   CURRENT PHARMACEUTICAL DESIGN

HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4

(2012) Milena Schiraldi et al.   JOURNAL OF EXPERIMENTAL MEDICINE

HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease

(2012) Helena Erlandsson Harris et al.   Nature Reviews Rheumatology

Severe Stroke Induces Long-Lasting Alterations of High-Mobility Group Box 1

(2012) Juliane Schulze et al.   STROKE

Evaluating the role of Toll-like receptors in diseases of the central nervous system

(2011) Michael Carty et al.   BIOCHEMICAL PHARMACOLOGY

Pathophysiology, treatment, and animal and cellular models of human ischemic stroke

(2011) Trent M Woodruff et al.   Molecular Neurodegeneration

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

(2010) Andreas Stang   EUROPEAN JOURNAL OF EPIDEMIOLOGY

HMBG1 Mediates Ischemia—Reperfusion Injury by TRIF-Adaptor Independent Toll-Like Receptor 4 Signaling

(2010) Qing-Wu Yang et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Functional Status of Peripheral Blood T-Cells in Ischemic Stroke Patients

(2010) Antje Vogelgesang et al.   PLoS One

A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release

(2010) H. Yang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The HMGB1 Receptor RAGE Mediates Ischemic Brain Damage

(2008) S. Muhammad et al.   JOURNAL OF NEUROSCIENCE